Suggest One No specific molecular structure known for this excipient.
CAS
9063381
UNII
5856J3G2A2
SYNONYMS
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Analogs cannot be located as there is no structure provided for this compound. Try a search by name.

Dosages

Route Formulation Per Unit Dose
Buccal Tablet 8.3MG
Oral Capsule 180MG
Oral Capsule 15.4MG
Oral Capsule, Coated Pellets 16.71MG
Oral Capsule, Delayed Action, Coated, Hard Gelatin 16MG
Oral Capsule, Delayed Action, Enteric Coated, Hard Gelatin 18.3MG
Oral Capsule, Enteric Coated Pellets 16.8MG
Oral Capsule, Extended Release 30MG
Oral Capsule, Hard Gelatin 20MG
Oral Capsule, Soft Gelatin 7.75MG
Oral Capsule, Sustained Action 18.6MG
Oral Dispersible Tablet 2.4MG
Oral Tablet 876MG
Oral Tablet (Immed./comp. Release), Coated 17MG
Oral Tablet (Immed./comp. Release), Film Coated 15MG
Oral Tablet (Immed./comp. Release), Film Coated 20MG
Oral Tablet (Immed./comp. Release), Uncoated, Chewable 50MG
Oral Tablet, Coated 73MG
Oral Tablet, Coated 15MG
Oral Tablet, Controlled Release 25.86MG
Oral Tablet, Delayed Action 34MG
Oral Tablet, Delayed Action, Enteric Coated 21MG
Oral Tablet, Delayed Release 37.5MG
Oral Tablet, Enteric Coated Particles 12MG
Oral Tablet, Extended Release 30MG
Oral Tablet, Extended Release 48MG
Oral Tablet, Film Coated 85.5MG
Oral Tablet, Film Coated 90MG
Oral Tablet, Multilayer, Coated 2MG
Oral Tablet, Orally Disintegrating 71.43MG
Oral Tablet, Orally Disintegrating 10.4MG
Oral Tablet, Sustained Action 15MG
Oral Tablet, Sustained Action, Coated
Oral Tablet, Sustained Action, Film Coated 10MG
Oral-21 Tablet 4MG
Oral-28 Tablet 4MG
Sublingual Tablet 5.5MG
Transmucosal Tablet 10MG

More Information

Usage Over Time

Data provided by OpenFDA

Comments